Orphan Drug Act

Results: 190



#Item
31Federal Register / Vol. 79, No[removed]Wednesday, December 10, [removed]Notices Information Line, 1–800–741–[removed]–443–0572 in the Washington, DC area). A notice in the Federal Register about last minute modifi

Federal Register / Vol. 79, No[removed]Wednesday, December 10, [removed]Notices Information Line, 1–800–741–[removed]–443–0572 in the Washington, DC area). A notice in the Federal Register about last minute modifi

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2014-12-10 03:06:27
32Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce

Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce

Add to Reading List

Source URL: www.nationalhealthcouncil.org

Language: English - Date: 2014-12-16 12:49:40
33National Institutes of Health / Epidemiology / Rare disease / Clinical research / Medical specialties / Orphan drug / European Organization for Rare Diseases / Orphanet / Orphan Drug Act / Medicine / Health / Cancer research

1 VI ICORD, Buenos Aires[removed]VI ICORD, Buenos Aires[removed]VI ICORD, Buenos Aires 2010

Add to Reading List

Source URL: icord.se

Language: English - Date: 2010-05-24 03:36:11
34History and Commitment from industry in the field of rare diseases and orphan drugs Dr. Erik Tambuyzer Senior Vice-President, Public Policy, Genzyme

History and Commitment from industry in the field of rare diseases and orphan drugs Dr. Erik Tambuyzer Senior Vice-President, Public Policy, Genzyme

Add to Reading List

Source URL: icord.se

Language: English - Date: 2010-09-20 11:12:19
357th Annual International Conference for Rare Diseases and Orphan Drugs Regulatory Aspects of Orphan Drugs – FDA Perspective Debra Lewis, OD, MBA Deputy Director

7th Annual International Conference for Rare Diseases and Orphan Drugs Regulatory Aspects of Orphan Drugs – FDA Perspective Debra Lewis, OD, MBA Deputy Director

Add to Reading List

Source URL: icord.se

Language: English - Date: 2012-07-24 07:43:02
36Microsoft PowerPoint - 4. Beakes Read Considerations for Global Development of Drugs for Rare Diseases3 [互換モード]

Microsoft PowerPoint - 4. Beakes Read Considerations for Global Development of Drugs for Rare Diseases3 [互換モード]

Add to Reading List

Source URL: icord.se

Language: English - Date: 2012-07-24 08:38:56
37Rare Pediatric Disease Priority Review Vouchers, Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: November 17, 2014

Rare Pediatric Disease Priority Review Vouchers, Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: November 17, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
38KEI Research Note 2014:3  (draft 2)    Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results    Elizabeth Rajasingh  November 27, 2014 

KEI Research Note 2014:3  (draft 2)    Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results    Elizabeth Rajasingh  November 27, 2014 

Add to Reading List

Source URL: keionline.org

Language: English - Date: 2014-11-17 12:49:45
39RepliGen   Sandford D. Smith President and Chief Executive 01ficer  Repligen Corporation

RepliGen Sandford D. Smith President and Chief Executive 01ficer Repligen Corporation

Add to Reading List

Source URL: www.clintonlibrary.gov

Language: English - Date: 2014-06-13 22:34:43
40Health / Medicine / Pharmacology / Drug discovery / Pharmaceutical industry / Orphan drug / Prescription Drug User Fee Act / Orphan Drug Act / Food and Drug Administration Modernization Act / Food and Drug Administration / Pharmaceutical sciences / Pharmaceuticals policy

UNITED STATES OF AMERICAPRIVATE FOOD & DRUG ADMINISTRATION

Add to Reading List

Source URL: www.fda.gov

Language: English